Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 141 - 160 of 481 trials
Titlesort icon Investigator Disease(s)
A Phase III Study of Ibrutinib (PCI-32765) plus R-CHOP Chemotherapy in Patients Newly Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL)
[Protocol 13-146]
Younes, Anas
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Ibritumomab Tiuxetan versus Observation in Older Patients with Diffuse Large B-Cell Lymphoma in Remission following R-CHOP
Newly Diagnosed
[Protocol 12-061]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Hormone Therapy with and without Chemotherapy in Patients with HER2-Negative Breast Cancer and 1-3 Positive Lymph Nodes and a Recurrence Score of 25 or Less
[Protocol 12-118]
Lake, Diana
  • Breast Cancer
A Phase III Study of Gemcitabine, Docetaxel, and Doxorubicin versus Observation in Women with High-Grade Uterine Leiomyosarcoma
[Protocol 12-177]
Hensley, Martee
  • Uterine Sarcoma
    • Leiomyosarcoma
A Phase III Study of Gemcitabine and Cisplatin with and without Bevacizumab in Patients with Advanced Transitional Cell Carcinoma
[Protocol 12-119]
Rosenberg, Jonathan
  • Bladder Cancer
  • Kidney Cancer
A Phase III Study of Etoposide/Platinum with and without Ipilimumab in Patients with Newly Diagnosed Advanced Small Cell Lung Cancer
[Protocol 12-202]
Pietanza, M. Catherine
  • Lung Cancer
  • Lung Cancer, Small Cell
A Phase III Study of Enzalutamide Alone or with Abiraterone and Prednisone for Metastatic Castration-Resistant Prostate Cancer
[Protocol 13-247]
Morris, Michael
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase III Study of Doxorubicin Alone or in Combination with TH-302 in Patients with Locally Advanced Inoperable or Metastatic Soft-Tissue Sarcoma
[Protocol 11-203]
Tap, William
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase III Study of Doxil with and without Vintafolide in Women with Platinum-Resistant Ovarian Cancer
[Protocol 13-046]
Konner, Jason
  • Ovarian Cancer
A Phase III Study of Doxil Alone and with Yondelis (Trabectedin) in Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 13-153]
O'Cearbhaill, Roisin
  • Ovarian Cancer
A Phase III Study of Dexamethasone plus MLN9708 or Standard Therapy in Patients with Recurrent or Persistent Systemic Light Chain Amyloidosis
[Protocol 13-088]
Landau, Heather
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
A Phase III Study of Dapsone Gel versus Moisturizer (Placebo) to Treat Cetuximab-Related Rash
[Protocol 13-012]
Lacouture, Mario
  • Colorectal Cancer
  • Head & Neck Cancer
A Phase III Study of CMX001 versus Placebo to Prevent Cytomegalovirus (CMV) Infection in Stem Cell Transplant Recipients Already Exposed to CMV
[Protocol 13-182]
Papanicolaou, Genovefa
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
A Phase III Study of Clofarabine versus Standard Therapy for Newly Diagnosed Acute Myeloid Leukemia in Older Adults
Newly Diagnosed
[Protocol 12-059]
Tallman, Martin
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase III Study of Chemotherapy After Radiation in Young Patients with Newly Diagnosed Ependymoma
[Protocol 11-090]
De Braganca, Kevin
  • Pediatric Brain Tumors
    • Brain Cancer
    • CNS Cancer
A Phase III Study of Cabozantinib versus Placebo in Patients with Liver Cancer Who Received Previous Therapy with Sorafenib
[Protocol 13-151]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase III Study of Cabozantinib versus Everolimus in Patients with Progressive Kidney Cancer
[Protocol 13-124]
Motzer, Robert
  • Kidney Cancer
A Phase III Study of Cabozantinib (XL184) versus Mitoxantrone/Prednisone in Men with Previously Treated Symptomatic Castration-Resistant Prostate Cancer
[Protocol 12-032]
Scher, Howard
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
    • Quality of Life
A Phase III Study of Brentuximab Vedotin versus Standard Therapy in Patients with Cutaneous T-Cell Lymphoma
[Protocol 13-008]
Horwitz, Steven
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Brentuximab Vedotin plus CHP versus CHOP Therapy for Patients with Previously Untreated CD30-Positive Peripheral T-Cell Lymphoma
[Protocol 13-055]
Horwitz, Steven
  • Lymphoma
    • Non-Hodgkin's Lymphoma